Sanofi continues tweaks to executive roster as new CEO Garijo settles in

With former Merck KGaA CEO Belén Garijo, M.D., Ph.D., now calling the shots at Sanofi, the French drugmaker continues to refine its executive roster, albeit with fewer high-profile C-suite departur | With former Merck KGaA CEO Belén Garijo, M.D., Ph.D., now calling the shots at Sanofi, the French drugmaker continues to refine its executive roster, albeit with fewer high-profile C-suite departures now than earlier in the year.